设计,合成,抗感染功效和机制研究新型基于Ru的复合物,含有替代阿达曼坦作为抗菌剂的新型复合物
Liqiang Wang1, Lianghong Liu2, Chunyan Zhang1
1Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science &Technology Normal University, Nanchang, 330013, China.
European journal of medicinal chemistry
|April 11, 2024
概括
基于的新型金属抗生素被开发用于对抗抗生素耐药的金黄色葡萄球菌 (S. aureus). 复杂的Ru1证明了卓越的疗效,低耐药性和有希望的体内结果,为抗菌药物发现提供了新的途径.
科学领域:
- 药用化学 医学化学
- 无机化学 无机化学 有机化学
- 微生物学 微生物学
背景情况:
- 黄金葡萄球菌 (S. aureus) 的抗生素耐药性对全球健康构成重大威胁.
- 开发具有高疗效和低耐药性频率的新型抗菌剂至关重要.
研究的目的:
- 合成和评估新型阿达曼坦功能化的以为基础的金属抗生素,用于对抗S. aureus.
- 研究最有前途的化合物的作用机制和体内疗效.
主要方法:
- 合成了三种新复合物:Ru1,Ru2和Ru3,其中包括亚达曼坦部分.
- 在体外对S. aureus进行抗微生物活性测试,包括耐药性频率分析.
- 作用机制研究涉及细菌膜透性和反应性氧物种 (ROS) 生产.
- 在动物感染模型中进行体内疗效评估.
主要成果:
- 与临床抗生素相比,Ru1复合物对S. aureus表现出优越的抗菌活性,耐药性发展较低.
- Ru1通过增加细菌膜的透性和促进ROS产生的双重作用.
- Ru1有效地抑制了生物膜的形成和外毒素的分泌,并强化了现有的抗生素.
- 在体内研究表明Ru1具有低毒性和显著的抗感染功效.
结论:
- 基于的金属抗生素与阿达曼坦部分功能化,代表了一类有前途的抗菌剂.
- 复合Ru1是进一步开发的强有力的候选人,作为S. aureus感染的新疗法.
- 这项研究为未来针对耐药细菌病原体的抗生素开发提供了基础.
更多相关视频
07:20Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
14.0K
10:51The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
Published on: April 10, 2015
12.1K
相关概念视频
Structure-Activity Relationships and Drug Design
710
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
710
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
